Roche CEO warns on high pharma valuations
July 23, 2015 at 03:23 AM EDT
Roche posted a 3 percent year-on-year rise in first-half sales, as demand for its oncology drugs helped offset the strength of the Swiss franc.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|